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Abstract
IMPORTANCE—Mild traumatic brain injury (mTBI), or concussion, in children is a rapidly 
growing public health concern because epidemiologic data indicate a marked increase in the 
number of emergency department visits for mTBI over the past decade. However, no evidence-
based clinical guidelines have been developed to date for diagnosing and managing pediatric 
mTBI in the United States.
OBJECTIVE—To provide a guideline based on a previous systematic review of the literature to 
obtain and assess evidence toward developing clinical recommendations for health care 
professionals related to the diagnosis, prognosis, and management/treatment of pediatric mTBI.
EVIDENCE REVIEW—The Centers for Disease Control and Prevention (CDC) National Center 
for Injury Prevention and Control Board of Scientific Counselors, a federal advisory committee, 
established the Pediatric Mild Traumatic Brain Injury Guideline Workgroup. The workgroup 
drafted recommendations based on the evidence that was obtained and assessed within the 
systematic review, as well as related evidence, scientific principles, and expert inference. This 
information includes selected studies published since the evidence review was conducted that were 
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deemed by the workgroup to be relevant to the recommendations. The dates of the initial literature 
search were January 1, 1990, to November 30, 2012, and the dates of the updated literature search 
were December 1, 2012, to July 31, 2015.
FINDINGS—The CDC guideline includes 19 sets of recommendations on the diagnosis, 
prognosis, and management/treatment of pediatric mTBI that were assigned a level of obligation 
(ie, must, should, or may) based on confidence in the evidence. Recommendations address 
imaging, symptom scales, cognitive testing, and standardized assessment for diagnosis; history 
and risk factor assessment, monitoring, and counseling for prognosis; and patient/family 
education, rest, support, return to school, and symptom management for treatment.
CONCLUSIONS AND RELEVANCE—This guideline identifies the best practices for mTBI 
based on the current evidence; updates should be made as the body of evidence grows. In addition 
to the development of the guideline, CDC has created user-friendly guideline implementation 
materials that are concise and actionable. Evaluation of the guideline and implementation 
materials is crucial in understanding the influence of the recommendations.
Mild traumatic brain injury (mTBI), or concussion, in children is a significant public health 
concern. From 2005 to 2009, children made more than 2 million outpatient visits and almost 
3 million emergency department (ED) visits for mTBI.1 In a subset of pediatric patients, 
postconcussive symptoms persist beyond 2 weeks and can continue for longer than 3 
months.2 Pathophysiologic injury and symptoms (both acute and long-term) affect a child’s 
ability to function physically, cognitively, and psychologically after mTBI.3–5
Consensus guidelines on the management of mTBI in adults have been developed.6,7 In 
2013, evidence-based guidelines related to the management of sports-related concussion in 
children and adults were published,8 and the Ontario Neurotrauma Foundation9 published an 
evidence-based guideline for diagnosing and managing pediatric concussion in 2014. To 
date, no broad, evidence-based clinical guidelines have been developed in the United States 
for the purposes of diagnosis, prognosis, and management/treatment of pediatric mTBI. 
Clinical guidance for health care professionals is critical to improving the health and safety 
of this vulnerable population.
This guideline provides evidence-based recommendations for health care professionals that 
were developed using a rigorous scientific process based on a comprehensive review of 
pediatric mTBI scientific evidence.10 Recommendations aim to provide health care 
professionals in primary care, outpatient specialty, inpatient, and emergency care settings in 
the United States with evidence-based guidance on the diagnosis and management of mTBI 
in children 18 years and younger.
Although “concussion,” “minor head injury,” and mTBI are frequently used interchangeably, 
they have different connotations for families, researchers, and health care professionals, 
allowing for misinterpretation.11–15 Therefore, the guideline recommends the clinical use of 
the single term mild traumatic brain injury. In 2004, the World Health Organization 
Collaborating Centre Task Force on Mild Traumatic BrainInjury,15 alongside the Mild 
Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest 
Group of the American Congress of Rehabilitation Medicine13 and the US Centers for 
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Disease Control and Prevention (CDC) Mild Traumatic Brain Injury Working Group Report 
to Congress,14 defined mTBI as “an acute brain injury resulting from mechanical energy to 
the head from external physical forces including: (1) 1 or more of the following: confusion 
or disorientation, loss of consciousness for 30 minutes or less, post-traumatic amnesia for 
less than 24 hours, and/or other transient neurological abnormalities such as focal signs, 
symptoms, or seizure; (2) Glasgow Coma Scale score of 13–15 after 30 minutes post-injury 
or later upon presentation for healthcare.”15(p7) A wide clinical and functional definition of 
pediatric mTBI was used for this guideline to be cognizant of the heterogeneity of 
presentations and outcomes of children with mTBI and to prevent the exclusion of children 
representing the more severe end of the mTBI spectrum. Specifically, pediatric patients were 
included with Glasgow Coma Scale (GCS) scores of 13 to 15 with or without the 
complication of intracranial injury (ICI) on neuroimaging and regardless of potentially 
requiring a hospital admission and/or neurosurgical intervention.
Methods
This guideline was based on a previous systematic review of the literature10 to obtain and 
assess evidence toward developing clinical recommendations for health care professionals 
related to the diagnosis, prognosis, and management/treatment of pediatric mTBI. The dates 
of the initial literature search were January 1, 1990, to November 30, 2012, and the dates of 
the updated literature search were December 1, 2012, to July 31, 2015. No institutional 
review board approval or participant informed consent was necessary.
Federal Advisory Committee Process
The CDC National Center for Injury Prevention and Control Board of Scientific Counselors 
(BSC), a federal advisory committee, established the Pediatric Mild Traumatic Brain Injury 
Guideline Workgroup to conduct a systematic review of the literature and draft clinical 
recommendations for health care professionals on the diagnosis, prognosis, and 
management/treatment of mTBI among children 18 years and younger. Before their 
participation and again near the end of the process, workgroup members and ad hoc experts 
were asked to disclose activities that could pose possible conflicts of interest. The CDC 
reviewed disclosed activities, and no conflicts of interest were identified. Furthermore, 
members of the BSC completed an Office of Government Ethics Form 450 to disclose 
relevant interests. Activities that did not pose a conflict but pertain to the topic of the 
guideline are disclosed. More information on the workgroup’s activities can be found in the 
systematic review10 and the Pediatric Mild Traumatic Brain Injury Guideline Workgroup 
Report (“Workgroup Report”).16
American Academy of Neurology Guideline
The Pediatric Mild Traumatic Brain Injury Guideline Workgroup conducted a systematic 
review of the literature and drafted clinical recommendations using the methods developed 
by the American Academy of Neurology.17 The process included clinical question 
identification and a systematic review. The review methods and findings that support the 
recommendations are reported in detail in the systematic review10 accompanying the 
guideline. Evidence was rated as part of the systematic review using a modified Grading of 
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Recommendations Assessment Development and Evaluation method. The workgroup 
drafted recommendations based on the systematic review, as well as related evidence, 
scientific principles, and expert inference, and categorized recommendations into 3 topic 
areas of the diagnosis, prognosis, and management/treatment of pediatric mTBI.
Clinical recommendations were collated and distributed among workgroup members in 
sequential rounds of voting to determine consensus. Workgroup members were presented 
with a series of potential recommendations and a rationale for each recommendation. The 
rationale was based on the research identified in the systematic review that was relevant to 
that recommendation (full rationales can be found in the Workgroup Report).16 Each 
workgroup member was requested to review and vote on all of the potential 
recommendations, and an 80% response was required for each recommendation before 
tabulation. After 4 rounds of voting, the workgroup achieved consensus on 46 clinical 
recommendations: 11 pertained to diagnosis, 12 were related to prognosis, and 23 focused 
on management/treatment. The Box describes how workgroup members assigned a level of 
confidence in the inference (ie, high, moderate, low, or very low) and a strength of 
recommendation (ie, level A, B, C, U, or R) for each recommendation. A more detailed 
description of the voting process, as well as summaries of the clinical evidence profile for 
each recommendation, are available in the eAppendix and the eTable in the Supplement. 
Using the Work-group Report, CDC grouped the 46 recommendations into 19 sets of 
recommendations on the diagnosis, prognosis, and management/treatment of pediatric mTBI 
that were assigned a level of obligation (ie, must, should, or may) based on confidence in the 
evidence and on clinical focus (eg, “General Health Care Provider Counseling of Prognosis” 
and “Cognitive Impairment Management/Treatment”) and constructed a draft Guideline on 
the Diagnosis and Management of Mild Traumatic Brain Injury Among Children 
(“Guideline”). As coauthors of the guideline, workgroup members individually reviewed the 
full draft guideline before public comment and peer review.
Public Comment and Peer Review
To obtain comments from the public on the full draft guideline, the CDC published a notice 
in the Federal Register (82 FR §45588) announcing the availability of the guideline for 
public comment during a 60-day period on Regulations.gov (docket number CDC-2017–
0089) from September 29 through November 28, 2017. In addition, public comments were 
received on the Workgroup Report during a BSC meeting open to the public. Because the 
guideline provides scientific information that could have a clear and substantial influence on 
public and private sector decisions, the guideline was peer reviewed per the final Office of 
Management and Budget information quality bulletin for peer review by 2 external, 
independent reviewers. The CDC carefully considered comments of the public and peer 
reviewers when developing and revising the guideline.
Recommendations
The guideline includes 19 sets of recommendations on the diagnosis, prognosis, and 
management/treatment of mTBI in children. A list of all of the recommendations is provided 
in the eTable in the Supplement.
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Diagnostic Recommendations
This section contains recommendations regarding the diagnostic utility of head imaging, 
symptom scales, cognitive testing, and serum biomarkers.
Risk Factors for ICI and Computed Tomography—Recommendation 1A: Health 
care professionals should not routinely obtain head computed tomography (CT) for 
diagnostic purposes in children with mTBI (moderate confidence in the inference 
[“moderate”]; strength of recommendation level B [“level B”]).
Recommendation 1B: Health care professionals should use validated clinical decision rules 
to identify children with mTBI at low risk for ICI in whom head CT is not indicated, as well 
as children who may be at higher risk for clinically important ICI and thus may warrant head 
CT. Existing decision rules,33 such as the Pediatric Emergency Care Applied Research 
Network (PECARN) decision rules, combine a variety of factors that, when assessed 
together, may increase the risk for more serious injury. Such risk factors include the 
following:
• Age younger than 2 years
• Vomiting
• Loss of consciousness
• Severe mechanism of injury
• Severe or worsening headache
• Amnesia
• Nonfrontal scalp hematoma
• Glasgow Coma Scale score less than 15
• Clinical suspicion for skull fracture (moderate; level B).
Recommendation 1C: For children diagnosed as having mTBI, health care professionals 
should discuss the risks of pediatric head CT in the context of risk factors for ICI with the 
patient and his/her family (moderate; level B).
Rationale: Up to 7.5% of children seen in the ED with mTBI will have ICI.18–32 
Identification of risk factors for ICI in children initially seen with possible mTBI in the acute 
setting is important to the diagnosis of more severe forms of TBI, further directing 
observation and the possible need for emergent head CT. Intracranial injury further 
influences the prognosis of patients with mTBI (see the Prognosis Recommendations 
section). Moderate evidence indicates that several risk factors identify patients with 
increased risk of ICI.20,22,33–35 Generally, risk factors are not sufficiently predictive in 
isolation to guide clinical care (excluding GCS score and clinical suspicion for skull 
fracture).36–40
Instead, strong clinical evidence shows that the use of clinical decision rules that combine 
multiple risk factors are more effective in identifying children at low risk for ICI.20,22,33,35 
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The risks of ICI provided in this document were not separated by isolated findings versus 
multiple findings. In addition, some of the reported risks of ICI could be higher in these 
recommendations because of the inclusion of studies of mTBI with GCS scores of 13 to 15. 
Head CT is the preferred diagnostic tool in acute care settings to rapidly identify ICI. 
However, higher doses of radiation attributable to this type of imaging in children have been 
associated in studies41–44 with an increase in the lifetime cancer risk, although the 
cumulative absolute risk appears small. Furthermore, certain pediatric populations will 
require sedation to obtain adequate neuroimaging, increasing the overall risk related to 
imaging processes.45 Families require clinical counseling regarding these risks to understand 
the best practices for the clinical care of their child. They should be aware that, after 
seemingly minor head injuries and mTBI, ICI resulting in clinically important outcomes, 
such as neurosurgical intervention, is rare.18–20,25–27,29,33,46–53 Clinical evaluation of the 
child with possible mTBI includes balancing the likelihood of potentially devastating 
complications of a more severe injury against the risks associated with head CT (as well as 
possible concomitant sedation for imaging).
Brain Magnetic Resonance Imaging—Recommendation 2: Health care professionals 
should not routinely use magnetic resonance imaging (MRI) in the acute evaluation of 
suspected or diagnosed mTBI (moderate; level B).
Rationale: No study met inclusion criteria addressing the use of brain MRI in the diagnosis 
of mTBI in children. An MRI is more sensitive in identifying structural abnormalities than 
CT,54,55 and MRI avoids the use of ionizing radiation associated with CT. Nevertheless, 
MRI more often requires sedation because of longer imaging acquisition times and is more 
expensive than CT; however, rapid-sequence MRI in nonsedated patients has recently been 
successfully used in children with suspected acute TBI.56
Single-Photon Emission CT—Recommendation 3: Health care professionals should not 
use single-photon emission CT (SPECT) in the acute evaluation of suspected or diagnosed 
mTBI (moderate; level B).
Rationale: The systematic review did not find any study that met our inclusion criteria 
addressing the use of SPECT in the diagnosis of mTBI in children. Furthermore, SPECT is 
not commonly used in the clinical setting of TBI in children, may require patient sedation, 
requires intravenous access in the child with the injection of a radiopharmaceutical, and may 
be more expensive than head CT alone because it is often used in conjunction with CT.
Skull Radiograph—Recommendation 4A: Skull radiographs should not be used in the 
diagnosis of pediatric mTBI (high; level B).
Recommendation 4B: Skull radiographs should not be used in the screening for ICI (high; 
level B).
Rationale: The systematic review identified 2 class III studies19,57 evaluating the use of skull 
radiographs in children after minor head injury. One study19 identified a possible skull 
fracture in 7.1% (95% CI, 4.0%−10.3%) of these patients. A radiograph is not the optimal 
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test to diagnose skull fracture with ICI after mTBI for several reasons: specifically, the 
literature reports that skull radiographs have 63% sensitivity for diagnosing a single skull 
fracture in children; a radiograph cannot detect ICIs, such as hemorrhage, shift from mid-
line, or edema; and radiographs use radiation for imaging.57 Clinical suspicion for skull 
fracture is a risk factor for ICI after mTBI in children.22,33–35 Head CT better detects ICIs 
and better characterizes skull fractures, making it the more appropriate diagnostic imaging 
choice when such imaging is clinically indicated.
Neuropsychological Tools, Including Symptom Scales, Computerized 
Cognitive Testing, and Standardized Assessment of Concussion—
Recommendation 5A: Health care professionals should use an age-appropriate, validated 
symptom rating scale as a component of the diagnostic evaluation in children seen with 
acute mTBI (moderate; level B).
Recommendation 5B: Health care professionals may use validated, age-appropriate 
computerized cognitive testing in the acute period of injury as a component of the diagnosis 
of mTBI (moderate; level C).
Recommendation 5C: The Standardized Assessment of Concussion should not be 
exclusively used to diagnose mTBI in children aged 6 to 18 years (moderate; level B).
Rationale: The consequences of missing a diagnosis of mTBI include failure to recommend 
appropriate treatment and management. In addition, an undiagnosed mTBI may contribute to 
the prolongation of symptoms and an increased risk of reinjury. The systematic review 
concluded that the Graded Symptom Checklist is useful in distinguishing children 6 years 
and older with mTBI from those without TBI within the first 2 days after injury.58 The 
review concluded that the Post Concussion Symptom Scale used in a computerized 
neurocognitive testing battery distinguishes high school athletes with mTBI from those 
without TBI within the first 4 days after injury.59,60 There are several other validated 
symptom scales that are reliable in the diagnosis of mTBI and have demonstrated validity at 
ages younger than high school (eg, the Health and Behavior Inventory61 and the Post-
Concussion Symptom Inventory62). Symptom rating scales can be applied quickly and 
inexpensively.
Two class II studies59,60 met inclusion criteria related to computerized cognitive testing and 
the diagnosis of mTBI in children. These studies specifically used a computerized 
neurocognitive testing battery and demonstrated that it probably distinguishes high school 
athletes with and without mTBI in the first 4 days after injury and may add sensitivity to the 
use of a symptom rating scale alone.59,60 While these 2 studies only reviewed 1 specific 
computerized neurocognitive battery, related evidence suggests that other validated 
computerized cognitive tests are also able to discriminate between children with and without 
mTBI.63,64
The systematic review demonstrated that cognitive screening using the Standardized 
Assessment of Concussion was not accurate in distinguishing those children with mTBI 
from those without mTBI because of lack of statistical significance from a single class III 
study.58
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Serum Markers—Recommendation 6: Health care professionals should not use 
biomarkers outside of a research setting for the diagnosis of children with mTBI (high; level 
R).
Rationale: There is insufficient evidence to currently recommend any of the studied 
biomarkers for the diagnosis of mTBI in children. In 2 class II studies,65,66 S100B was 
shown to be associated with a low sensitivity but high specificity in patients with severe TBI, 
with no discrimination in mild to moderate TBI. In a class II study,65 tau protein levels were 
significantly different across pediatric patients with mTBI with normal head CT, those with 
abnormal CT, and among non-TBI controls. A single class II study66 explored the use of 
autoantibodies against glutamate receptors and oxide metabolites as a marker to discriminate 
between severe and mTBI in children. There was good discrimination between the 2 groups; 
however, further data are needed. A single class III study67 examined multiplex bead array 
biomarkers in a small number of infants with TBI compared with controls and found 
significant differences in a number of biomarkers. Related studies68–71 have demonstrated 
associations between neuronal ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic 
protein biomarker levels and ICI in adults, and a single class II study72 of 23 children found 
insufficient evidence for the use of these biomarkers in distinguishing children with or 
without mTBI.
Prognostic Recommendations
This section contains recommendations related to counseling on prognosis, assessment of 
the premorbid history and cumulative risk, use of tools to track recovery, and interventions 
for patients with a poor prognosis.
General Health Care Professional Counseling of Prognosis—Recommendation 
7A: Health care professionals should counsel patients and families that most (70%−80%) 
children with mTBI do not show significant difficulties that last more than 1 to 3 months 
after injury (moderate; level B).
Recommendation 7B: Health care professionals should counsel patients and families that, 
although some factors predict an increased or decreased risk for prolonged symptoms, each 
child’s recovery from mTBI is unique and will follow its own trajectory (moderate; level B).
Rationale: Recovery from pediatric mTBI is variable,73–75 and no single factor can predict 
symptom resolution or outcome.76 Symptoms experienced by most children with mTBI 
resolve within 1 to 3 months after injury.73 A single class III study77 reported that providing 
informational booklets to families that counseled on symptoms and coping strategies for 
children with mTBI resulted in improved patient outcomes at 3 months. Related studies78,79 
in children and adults with mTBI report direct patient benefits of counseling by health care 
professionals. Public health campaigns have emphasized the importance of parent and 
family education in mTBI because health outcomes in general are optimized through patient 
health literacy and the resulting behavior modifications.80–82 Important aspects of health 
care professional counseling are outlined in recommendation 12.
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Prognosis Related to the Premorbid Conditions—Recommendation 8A: Health care 
professionals should assess the premorbid history of children either before injury as a part of 
pre-participation athletic examinations or as soon as possible after injury in children with 
mTBI to assist in determining prognosis (moderate; level B).
Recommendation 8B: Health care professionals should counsel children and families 
completing preparticipation athletic examinations and children with mTBI, as well as their 
families, that recovery from mTBI might be delayed in those with the following:
• Premorbid histories of mTBI
• Lower cognitive ability (for children with an intracranial lesion)
• Neurological or psychiatric disorder
• Learning difficulties
• Increased preinjury symptoms (ie, similar to those commonly referred to as 
“postconcussive”)
• Family and social stressors (moderate; level B).
Rationale: Evidence of varying strength indicates that there is an increased risk of delayed 
recovery or prolonged symptoms associated with the premorbid conditions listed above in 
children with mTBI.83–89
Assessment of Cumulative Risk Factors and Prognosis—Recommendation 9A: 
Health care professionals should screen for known risk factors for persistent symptoms in 
children with mTBI (moderate; level B).
Recommendation 9B: Health care professionals may use validated prediction rules, which 
combine information about multiple risk factors for persistent symptoms, to provide 
prognostic counseling to children with mTBI evaluated in ED settings (high; level C).
Rationale: Evidence of varying strength indicates that a variety of noninjury (eg, 
demographic) and injury-related factors predict outcomes in pediatric mTBI. Specifically, 
symptoms may last longer among older children/adolescents,73,90,91 children of Hispanic 
race/ethnicity (compared with white race/ethnicity),91 children of lower socioeconomic 
status,89,91 children with more severe presentations of mTBI75,92,93 (including those 
associated with ICI),92,94 and children reporting more acute postconcussion symptoms.
74,84,95
 In addition, headaches persist longer in girls.90 However, no single factor is strongly 
predictive of outcome. Only 1 prediction rule has been validated to date. It is based on a 
2016 study96 of 3063 children with mTBI seen in the ED and demonstrated that an 
empirically derived set of risk factors predicted the risk of persistent postconcussion 
symptoms at 28 days.
Assessment Tools and Prognosis—Recommendation 10A: Health care professionals 
should use a combination of tools to assess recovery in children with mTBI (moderate; level 
B).
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Recommendation 10B: Health care professionals should use validated symptom scales to 
assess recovery in children with mTBI (moderate; level B).
Recommendation 10C: Health care professionals may use validated cognitive testing 
(including measures of reaction time) to assess recovery in children with mTBI (moderate; 
level C).
Recommendation 10D: Health care professionals may use balance testing to assess recovery 
in adolescent athletes with mTBI (moderate; level C).
Rationale: No single assessment tool is strongly predictive of outcome in children with 
mTBI.76 However, multiple tools have shown utility in the assessment of individual patients 
and their recovery from mTBI.97–99 Symptom scales and cognitive testing (including 
measures of reaction time) have the strongest evidence in terms of their contribution to 
predicting outcomes and assessing recovery.100 Less evidence supports balance testing as a 
predictor for prognosis in children, but it has shown utility in older adolescent athletes.101
Interventions for mTBI With Poor Prognosis—Recommendation 11A: Health care 
professionals should closely monitor children with mTBI who are determined to be at high 
risk for persistent symptoms based on their premorbid history, demographics, and/or injury 
characteristics (high; level B).
Recommendation 11B: For children with mTBI whose symptoms do not resolve as expected 
with standard care (ie, within 4–6 weeks), health care professionals should provide or refer 
for appropriate assessments and/or interventions (moderate; level B).
Rationale: The symptoms experienced by most children with mTBI resolve within 1 to 3 
months after injury,73 but some children are at risk for persistent symptoms and delayed 
recovery (ie, those who demonstrate certain premorbid characteristics and other risk factors 
[see recommendations 8 and 9]). Children with mTBI who are at high risk for persistent 
symptoms or delayed recovery are more likely to require intervention than children at low 
risk. Health care professionals can more effectively counsel patients with mTBI when they 
have assessed prognostic risk factors.
Recommendations Related to Management/Treatment
This section contains recommendations related to the provision of patient/family education, 
counseling related to physical/cognitive rest, assessment of patient psychosocial/emotional 
support, and managing a patient’s return to school. In addition, this section contains 
recommendations related to the management/treatment of headache, vestibulo-oculomotor 
dysfunction, sleep problems, and cognitive impairment.
Patient/Family Education and Reassurance—Recommendation 12: In providing 
education and reassurance to the family, the health care professional should include the 
following information:
• Warning signs of more serious injury
• Description of injury and expected course of symptoms and recovery
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• Instructions on how to monitor postconcussive symptoms
• Prevention of further injury
• Management of cognitive and physical activity/rest
• Instructions regarding return to play/recreation and school
• Clear clinician follow-up instructions (high; level A).
Rationale: There is no definitive evidence to indicate that specific methods of patient and 
family education and reassurance after pediatric mTBI are associated with clear 
improvements in patient health outcomes. Regardless, public health campaigns have 
emphasized the importance of parent and family education in mTBI because health 
outcomes in general are optimized through health literacy and the resulting behavior 
modifications.80–82 Patient and family education and reassurance are key components of 
mTBI care initiatives and ED discharge instructions.77–79,102 Standardized processes of 
evaluation and discharge instruction provide significant benefit with respect to pediatric 
patient mTBI outcomes.78
Cognitive/Physical Rest and Aerobic Treatment—Recommendation 13A: Health 
care professionals should counsel patients to observe more restrictive physical and cognitive 
activity during the first several days after mTBI in children (moderate; level B).
Recommendation 13B: Following these first several days, health care professionals should 
counsel patients and families to resume a gradual schedule of activity that does not 
exacerbate symptoms, with close monitoring of symptom expression (number and severity) 
(moderate; level B).
Recommendation 13C: After the successful resumption of a gradual schedule of activity (see 
recommendation 13B), health care professionals should offer an active rehabilitation 
program of progressive reintroduction of noncontact aerobic activity that does not 
exacerbate symptoms, with close monitoring of symptom expression (number and severity) 
(high; level B).
Recommendation 13D: Health care professionals should counsel patients to return to full 
activity when they return to premorbid performance if they have remained symptom free at 
rest and with increasing levels of physical exertion (moderate; level B).
Rationale: Historically, “rest” has been a foundation in the treatment of acute mTBI.103,104 
However, scientific evidence supporting its timing, duration, and efficacy is limited.105 
Related evidence suggests that rest or reduction in cognitive/physical activity is beneficial 
immediately after mTBI and, for those who are slow to recover, may help accelerate 
recovery.106–108 The postinjury period is a posited temporal window of vulnerability for 
reinjury109,110 because the reinjury threshold is lower during recovery and the symptom 
burden may be greater.111–113 On the other hand, studies114–117 in children and adults with 
prolonged symptoms beyond 4 weeks demonstrate that physical exercise, performed below 
symptom exacerbation, reduced postconcussive symptoms in active rehabilitation models.
Lumba-Brown et al. Page 12
JAMA Pediatr. Author manuscript; available in PMC 2020 February 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The optimal timing to initiate an aerobic program after pediatric mTBI has not been 
established, and only a limited number of studies114–116 have applied this treatment to 
patients with symptoms persisting past 4 weeks. Related evidence suggests that early rest 
(within the first 3 days of injury) may be beneficial103,118 but that inactivity beyond this 
period for most children may worsen their self-reported symptoms.119
Psychosocial/Emotional Support—Recommendation 14: Health care professionals 
may assess the extent and types of social support (ie, emotional, informational, instrumental, 
and appraisal) available to children with mTBI and emphasize social support as a key 
element in the education of caregivers and educators (moderate; level C).
Rationale: Social support has proved useful in promoting the recovery of persons with TBI, 
particularly those with cognitive deficits.113,120 Limited research with those who have 
experienced an mTBI demonstrates similar benefits.121,122 Direct, ancillary, and 
extrapolated evidence is strongly suggestive of the utility of social support in the 
management of mTBI.
Return to School—Recommendation 15A: To assist children returning to school after 
mTBI, medical and school-based teams should counsel the student and family regarding the 
process of gradually increasing the duration and intensity of academic activities as tolerated, 
with the goal of increasing participation without significantly exacerbating symptoms 
(moderate; level B).
Recommendation 15B: Return-to-school protocols should be customized based on the 
severity of postconcussion symptoms in children with mTBI as determined jointly by 
medical and school-based teams (moderate; level B).
Recommendation 15C: For any student with prolonged symptoms that interfere with 
academic performance, school-based teams should assess the educational needs of that 
student and determine the student’s need for additional educational supports, including those 
described under pertinent federal statutes (eg, Individuals With Disabilities Education Act 
§504)123 (high; level B).
Recommendation 15D: Postconcussion symptoms and academic progress in school should 
be monitored collaboratively by the student, family, health care professional(s), and school 
teams, who jointly determine what modifications or accommodations are needed to maintain 
an academic workload without significantly exacerbating symptoms (high; level B).
Recommendation 15E: The provision of educational supports should be monitored and 
adjusted on an ongoing basis by the school-based team until the student’s academic 
performance has returned to preinjury levels (moderate; level B).
Recommendation 15F: For students who demonstrate prolonged symptoms and academic 
difficulties despite an active treatment approach, health care professionals should refer the 
child for a formal evaluation by a specialist in pediatric mTBI (moderate;levelB).
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Rationale: Return to school after mTBI must be carefully planned given the injury 
symptoms (eg, headaches and fatigue interfering with learning, greater problems 
concentrating on schoolwork, and difficulty taking notes) that can affect learning and 
performance.124,125 Limited evidence exists to guide the timing or progression of return to 
activity in relation to academic activities.119 Consensus-based recommendations for 
returning to school after mTBI attempt to minimize cognitive and physical overexertion, 
while encouraging a prompt return to school to avoid the deleterious effects of prolonged 
school absence.104 Return-to-school protocols affirm the need for continued collaboration 
among medical, school, and family systems to gradually adjust interventions and return the 
child to full participation without significant worsening of symptoms.104,124,126–129 The 
protocols target the student’s symptoms as the focus of intervention, linking specific 
accommodations in efforts to limit symptom expression. Because postconcussive symptoms 
resolve at different rates in different children after mTBI, individualization of return-to-
school programming is necessary. To protect their legal right to an appropriate education, 
children with mTBI who have a greater symptom burden and prolonged recoveries may 
require formal educational planning incorporating protections under federal statutes.123,130
Posttraumatic Headache Management/Treatment—Recommendation 16A: Health 
care professionals in the ED should clinically observe and consider obtaining a head CT in 
children seen with severe headache, especially when associated with other risk factors and 
worsening headache after mTBI, to evaluate for ICI requiring further management in accord 
with validated clinical decision-making rules (high; level B).
Recommendation 16B: Children undergoing observation periods for headache with acutely 
worsening symptoms should undergo emergent neuroimaging (high; level B).
Recommendation 16C: Health care professionals and caregivers should offer nonopioid 
analgesia (ie, ibuprofen or acetaminophen) to children with painful headache after acute 
mTBI but also provide counseling to the family regarding the risks of analgesic overuse, 
including rebound headache (moderate; level B).
Recommendation 16D: Health care professionals should not administer 3% hypertonic 
saline to children with mTBI for treatment of acute headache outside of a research setting at 
this time (moderate; level R).
Recommendation 16E: Chronic headache after mTBI is likely to be multifactorial; therefore, 
health care professionals should refer children with chronic headache after mTBI for 
multidisciplinary evaluation and treatment, with consideration of analgesic overuse as a 
contributory factor (high; level B).
Rationale: Children seen with a headache, including worsening or severe headache, after 
mTBI with GCS scores of 13 to 15 are probably at moderate risk for ICI, as reflected by a 
risk difference of 1.9% (95% CI, 0.1%−3.6%) from 3 class I studies20,22,33 and 1 class II 
study.35 This evidence supports the contention that the risk of not identifying more severe 
forms of TBI manifesting as a progressive, severe headache in a child with or without other 
risk factors outweighs the risk of ionizing radiation. Risk of isolated severe headache after 
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mTBI for ICI was not supported in a large study40 when GCS scores were 14 or above. 
Painful headache in children requires intervention. Nonopioid analgesics, such as ibuprofen 
and acetaminophen, are often effective in treating headaches in children, and opioids are not 
generally recommended as therapy for headaches.62,131,132 Nonopioid analgesic overuse 
carries important risks of toxic effects and rebound headache.133 There is insufficient 
evidence to currently recommend the administration of 3% hypertonic saline as a treatment 
for acute headache after mTBI in children. Among children in the ED, a single class I 
study134 found that 3% hypertonic saline possibly decreases pain with headache 
immediately after administration but not at 3 days after intervention.
Vestibulo-Oculomotor Dysfunction Management/Treatment—Recommendation 
17: Health care professionals may refer children with subjective or objective evidence of 
persistent vestibule-oculomotor dysfunction after mTBI to a program of vestibular 
rehabilitation (moderate; level C).
Rationale: A single class II study135 reported that vestibular and oculomotor dysfunction 
may contribute to the diagnosis of mTBI and longer symptom duration. Limited evidence 
suggests that early vestibulo-ocular and cervicovestibular physical therapy may be of benefit 
for patients seen with subjective reports (symptoms of dizziness) or objective physical 
examination findings.136–139
Sleep Management/Treatment—Recommendation 18A: Health care professionals 
should provide guidance on proper sleep hygiene methods to facilitate recovery from 
pediatric mTBI (moderate; level B).
Recommendation 18B: If sleep problems emerge or continue despite appropriate sleep 
hygiene measures, health care professionals may refer children with mTBI to a sleep 
disorder specialist for further assessment (moderate; level C).
Rationale: Receiving adequate sleep has been shown to facilitate health140 and, when not 
adequate, adversely affects medical conditions, including TBI.141–143 While limited 
evidence supports a recommendation for sleep hygiene specifically in children with mTBI, 
related evidence in adults with TBI indicates benefits, suggesting that the maintenance of 
appropriate sleep and the management of disrupted sleep may be a critical target of 
treatment for the child with mTBI.144–146
Cognitive Impairment Management/Treatment—Recommendation 19A: Health care 
professionals should attempt to determine the etiology of cognitive dysfunction within the 
context of other mTBI symptoms (moderate; level B).
Recommendation 19B: Health care professionals should recommend treatment for cognitive 
dysfunction that reflects its presumed etiology (high; level B).
Recommendation 19C: Health care professionals may refer children with persisting 
problems related to cognitive function for a formal neuropsychological evaluation to assist in 
determining the etiology and recommending targeted treatment (high; level C).
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Rationale: Cognitive impairment occurs after mTBI and includes the areas of attention, 
memory and learning, response speed, and aspects of executive functions.59,60,147,148 
Cognitive impairment may be directly related to the pathology of the brain injury (ie, 
impaired neurotransmission) but may also reflect secondary effects of other symptoms (eg, 
ongoing headache pain, fatigue/low energy, and low frustration tolerance) that may produce 
a disruption in cognitive processing. Neuropsychological evaluations can assist in 
determining the etiology of cognitive impairment and directing treatment.148
Conclusions
The science of managing mTBI in children is rapidly evolving and expanding. This 
guideline identifies the best practices based on the current evidence for health care 
professionals in primary care, outpatient specialty, inpatient, and emergency care settings; 
updates may be made as the body of evidence grows. Suggestions related to key future 
directions for research are described in the systematic review10 that informed this guideline.
Equally as important as the development of this guideline is a multifaceted approach to its 
implementation.149,150 The CDC created user-friendly implementation materials151 that are 
concise and actionable.150 These materials include a screening tool, online training, and fact 
sheets. Patient discharge instructions, inclusive of a return-to-activity protocol, and 
symptom-based recovery tips were also created.152 The CDC will leverage its HEADS UP 
campaign (http://www.cdc.gov/HEADSUP) to support distribution of the guideline 
implementation materials through leading organizations and digital platforms (ie, web, 
mobile, and electronic health records). Partner organizations’ efforts are critical to ensure 
sustainability of this effort nationwide. Finally, examining the effectiveness of the guideline 
and implementation materials is a research priority of the CDC’s Injury Center153; 
evaluation is crucial for understanding the influence of the recommendations, both intended 
and unintended, and for revising future recommendations and implementation materials.
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Refer to Web version on PubMed Central for supplementary material.
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Box.
Assigning Level of Confidence in the Inference and Strength of 
Recommendation
Level of Confidence in the Inference
• As part of the systematic review, the American Academy of Neurology 
Classification of Evidence Scheme17 was used to assign the risk of bias and 
assign a class for each study, including class I (eg, high-quality RCTs), class 
II (eg, RCTs with significant limitations), class III (eg, other controlled 
studies), and class IV (eg, no measures of the effectiveness or statistical 
precision).
• Workgroup members were presented with a series of potential 
recommendations and a rationale for each recommendation. The rationale was 
based on the research identified in the systematic review, as well as related 
evidence that pertained to the recommendation.
• Level of confidence in the inference was based on workgroup members’ 
assessment of the cogency of the rationale supporting each recommendation 
and was assigned on the basis of the following 5 domains rated by workgroup 
members: rationale is logical, evidence statements are accurate, axioms are 
true, related evidence is strong and applicable, and internal inferences 
logically follow.
• Levels include high, moderate, low, or very low.
Strength of Recommendationa
There is not a direct correspondence between the class of studies and confidence in the 
inference or strength of recommendation. While the class of studies is an important 
consideration, the methods that were used consider a number of additional factors in 
deriving these judgments. The determination by the workgroup of strength of 
recommendation was initially anchored to level of confidence in the inference but was 
modified on the basis of workgroup members’ assessment of each recommendation, 
including the following: the importance of the outcome, benefit relative to harm, expected 
variation in patient preferences, financial burden relative to benefit expected, and the 
feasibility of the intervention (eg, the availability).
• Level A: The recommendation almost always should be followed.
• Level B: The recommendation usually should be followed.
• Level C: The recommendation may sometimes be followed.
• Level U: There is insufficient evidence to make a recommendation.
• Level R: The intervention generally should not be done outside of a research 
setting (applicable only to recommendations related to interventions).
Abbreviation: RCT, randomized clinical trial.
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a
 More detailed information related to how workgroup members assigned level of 
confidence in the inference and strength of recommendation can be found in the 
eAppendix in the Supplement.
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Key Points
Question
Based on current evidence, what are best practices for diagnosis, prognosis, and 
management/treatment of pediatric mild traumatic brain injury (mTBI)?
Findings
Based on a previous systematic review of the literature, this guideline includes 19 sets of 
recommendations on diagnosis, prognosis, and management/treatment of pediatric mTBI. 
Each recommendation was assigned a level of obligation (ie, must, should, or may) based 
on confidence in the evidence.
Meaning
Clinical guidance for health care professionals is critical to improving health and safety 
of this vulnerable population; the recommendations represent current best practices and 
comprise the first evidence-based clinical guideline to date for diagnosing and managing 
pediatric mTBI in the United States.
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